Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience

OBJECTIVES: To evaluate and categorize the survival benefit of tricyclic antidepressants (TCAs) in lung cancer patients based on systematic computational drug repositioning data. METHODS: Data were retrospectively extracted from the medical records of non-small cell lung cancer (NSCLC) patients from...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel Karim, Nagla Fawzy, Hassan, Rammey, Siddiqi, Nabeela Iffat, Eldessouki, Ihab, Gaber, Ola, Rahouma, Mohamed, Kamel, Mohamed, Yellu, Mhender, Gulati, Shuchi, Xie, Changchun, Magdy, Mohamed, Pruemer, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045662/
https://www.ncbi.nlm.nih.gov/pubmed/31640444
http://dx.doi.org/10.1177/0300060519862469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045662/
https://www.ncbi.nlm.nih.gov/pubmed/31640444
http://dx.doi.org/10.1177/0300060519862469

Ejemplares similares